HYBRID EVENT: You can participate in person at Tokyo, Japan or Virtually from your home or work.
Denise Steiner Reis Longhi, Speaker at Dermatology Congress 2022
Mogi das Cruzes University, Brazil
Title : Meta-analyses about tranexamic acid in the treatment of melasma

Abstract:

This lecture will talk about the use of tranexamic acid for the treatment of melasma.

Melasma is a prevalent and chronic disease which we don’t know the exact mechanism of action. There are a lot of stimuli to provoke it, for example: sun, hormones, stress, heat, local trauma and skin irritation.

Tranexamic acid is an antifibrinolytic drug that prevents the transformation of plasminogen into plasmin, thus avoiding all the provocative stimuli.

The dosage we use systemic tranexamic acid to treat melasma is 500mg once a day during four to six months.

We have just finished a meta-analysis study, and I will comment the results.

 

Biography:

Denise Steiner, MD, PhD

President of the Brazilian Society of Dermatology - 2013/2014

Coordinator of the Chapter of the College Cosmetics College Ibero Latino – CILAD

São Paulo, Brazil

General Secretary of the Congress College Ibero Latino - CILAD Rio de Janeiro 2014

Denise Steiner, MD, PhD

President of the Brazilian Society of Dermatology - 2013/2014

Coordinator of the Chapter of the College Cosmetics College Ibero Latino – CILAD

São Paulo, Brazil

General Secretary of the Congress College Ibero Latino - CILAD Rio de Janeiro 2014.

Watsapp